Results 111 to 120 of about 87,239 (208)

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study. [PDF]

Cancer Manag Res
Dinc Sonusen S, Sucuoglu Isleyen Z, Aydin O, Erciyestepe M, Sakin A, Gurdal N, Urun M, Mermit Ercek B, Bilici M, Gurbuz HS, Gunenc S, Akyel R, Celik E, Erturk K, Atci MM.   +14 more
europepmc   +1 more source

Retrograde-antegrade rendezvous recanalization for complete cervical esophageal obstruction after chemoradiotherapy: a novel organ-preserving approach. [PDF]

Endoscopy
Kono M, Ominami M, Kitagawa D, Takahashi S, Emoto M, Fukunaga S, Fujiwara Y.   +6 more
europepmc   +1 more source

Definitive radiotherapy provides comparable survival with lower toxicity compared with concurrent chemoradiotherapy after long-course induction chemoimmunotherapy in unresectable non-small-cell lung cancer. [PDF]

Ther Adv Med Oncol
Chang X, Liang H, Xiao J, Yang D, Yu J, Shan J, Dong X, Deng W, Zhao Y, Jiang L, Long L, Teng Y, Yu H, Yu R, Ma S, Shi A.   +15 more
europepmc   +1 more source

Bone marrow-sparing radiotherapy in women with cervical cancer treated with radiochemotherapy. [PDF]

Cochrane Database Syst Rev
Cantidio FS, Costa Diniz PH, Gil G, Silva-Filho AL.   +3 more
europepmc   +1 more source

Correction to "Macro Habitat-Based T2-Weighted MRI Radiomics and Deep Learning Fusion for Predicting Treatment Response and Prognosis After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer". [PDF]

Cancer Med
europepmc   +1 more source

Endometrial Cancer Recurrence Risk Following Robotic Hysterectomy. [PDF]

Curr Oncol
Zhu S, Wiebe E, Frerichs H, Ghosh S, Gill J, Habsi ZA, Beruar A, Pin S.   +7 more
europepmc   +1 more source

Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case report. [PDF]

Oncol Lett
Kong Y, Zhu L, Xiao Y.
europepmc   +1 more source

A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery. [PDF]

Future Oncol
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS.   +22 more
europepmc   +1 more source

Complete pathological response to neoadjuvant chemoradiotherapy in Crohn's disease-associated fistula adenocarcinoma: a case report. [PDF]

Front Med (Lausanne)
Dahmeni W, Souilem E, Hassen H, Ghdiri Y, Ahlem Z, Dahmoul A, Slama AB, Brahem A, Jaziri H, Mestiri S, Elleuch N, Hmissa S, Ksiaa M.   +12 more
europepmc   +1 more source

Neoadjuvant Therapy in Locally Advanced Rectal Cancer-What Result Should We Expect? [PDF]

Medicina (Kaunas)
Stefan RE, Constantin A, Dinu D, Achim F, Rotariu A, Grama F, Liscu HD, Iordache L, Scripcariu DV, Rasuceanu A, Constantinoiu S, Predescu D.   +11 more
europepmc   +1 more source